Dr. Armando Acevedo

Pediatrics
Brownsville Medical Center Inc
2400 NW 54th St, 
Miami, FL 
Offers Telehealth
Brownsville Medical Center Inc
2400 NW 54th St, 
Miami, FL 

Overview

Armando Acevedo is a primary care provider, practicing in Pediatrics in Miami, Florida.

His clinical expertise encompasses Asthma, Obesity, Asthma in Children, and Obesity in Children.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 8 clinical trials.

Specialties

Pediatrics

Licenses

Specialist in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
View 7 Less Insurance Carriers -

Locations

Brownsville Medical Center Inc
2400 NW 54th St, Miami, FL 33142

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
Enrollment Status: Completed
Publish Date: February 10, 2026
Intervention Type: Biological
Study Phase: Phase 3
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
A Randomised, Double-blind, Parallel Group, Multicentre, Stratified, Study Evaluating the Efficacy and Safety of Once Daily Fluticasone Furoate/Vilanterol Inhalation Powder Compared to Once Daily Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Participants Aged 5 to 17 Years Old (Inclusive) Currently Uncontrolled on Inhaled Corticosteroids
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Drug
Study Drugs: Fluticasone Furoate, Vilanterol
Study Phase: Phase 3
Study HZA114971, A Multicentre Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of a One-Year Regimen of Orally Inhaled Fluticasone Furoate 50 mcg Once Daily on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma
Study HZA114971, A Multicentre Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of a One-Year Regimen of Orally Inhaled Fluticasone Furoate 50 mcg Once Daily on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma
Enrollment Status: Completed
Publish Date: January 17, 2024
Intervention Type: Drug
Study Phase: Phase 4
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder
A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Terminated
Publish Date: June 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Fixed-Dose, Efficacy, and Safety Study of SHP465 in Children Aged 6-12 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Fixed-Dose, Efficacy, and Safety Study of SHP465 in Children Aged 6-12 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Enrollment Status: Completed
Publish Date: June 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

1 Total Publications

A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.
A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.
Journal: The Journal of infectious diseases
Published: July 11, 2024
Similar Doctors
Expertise in
19
conditions
Dr. Daniel Nassau
Pediatrics
Expertise in
19
conditions
Dr. Daniel Nassau
Pediatrics

Office

3200 SW 60th Ct Ste 104, 
Miami, FL 
 (7.6 miles away)
305-669-6448
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Nassau is a Pediatrics provider practicing medicine in Miami, Florida. Dr. Nassau is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Varicocele, Testicular Torsion, Undescended Testicle, Klinefelter Syndrome, and Orchiectomy.

Expertise in
33
conditions
Dr. Rafael Gosalbez
Pediatrics
Expertise in
33
conditions
Dr. Rafael Gosalbez
Pediatrics

Office

3200 SW 60th Ct Ste 104, 
Miami, FL 
 (7.6 miles away)
305-669-6448
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rafael Gosalbez is a Pediatrics provider practicing medicine in Miami, Florida. Dr. Gosalbez is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Hypospadias, Varicocele, Undescended Testicle, and Epispadias.

Expertise in
28
conditions
Dr. Lee Friedman
Pediatrics
Expertise in
28
conditions
Dr. Lee Friedman
Pediatrics

Office

8740 N Kendall Dr Ste 117, 
Miami, FL 
 (13.6 miles away)
305-709-2211
Languages Spoken:
English
See accepted insurances

Lee Friedman is a Pediatrics provider practicing medicine in Miami, Florida. Dr. Friedman is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Strabismus, Esotropia, Retinopathy of Prematurity, and Brown Syndrome.

Frequently Asked Questions about Dr. Armando Acevedo

How do I make an appointment with Dr. Armando Acevedo?

You can book an appointment with Dr. Armando Acevedo by calling their office at 305-633-9090. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Armando Acevedo a top-rated expert for Asthma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Armando Acevedo is classified as an Experienced expert for Asthma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Armando Acevedo specialize in?

While Dr. Armando Acevedo is a Pediatrics, they have specific expertise in Asthma, Obesity, and Asthma in Children. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Armando Acevedo participate in research or clinical trials?

Yes. Dr. Armando Acevedo has published 1 articles and abstracts on conditions like Asthma. You can view a list of Dr. Armando Acevedo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Armando Acevedo accept my insurance?

Dr. Armando Acevedo accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 305-633-9090 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Acevedo's expertise for a condition
ConditionClose
        View All 53 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile